Elanco Animal Health (ELAN) Assets (2017 - 2026)
Elanco Animal Health (ELAN) posted Assets of $13.2 billion for Q1 2026, down 1.02% sequentially from $13.4 billion in Q4 2025, and up 2.17% YoY from $12.9 billion in Q1 2025.
Elanco Animal Health (ELAN) Assets (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Assets for 10 years, with the latest figure at $13.2 billion in Q1 2026.
- Quarterly Assets rose 2.17% year-over-year to $13.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 billion (up 2.17% YoY) and the FY2025 annual result came in at $13.4 billion, up 5.9% from the prior year.
- Assets retreated to $13.2 billion in Q1 2026 per ELAN's latest filing, from $13.4 billion in the prior quarter.
- Over five years, Assets peaked at $16.3 billion in Q1 2022 and troughed at $12.6 billion in Q4 2024.
- A 5-year average of $14.3 billion and a median of $14.0 billion in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets retreated 12.86% in 2024, then grew 5.9% in 2025.
- Over 5 years, Assets stood at $15.5 billion in 2022, then dropped by 7.29% to $14.4 billion in 2023, then retreated by 12.17% to $12.6 billion in 2024, then climbed by 5.9% to $13.4 billion in 2025, then fell by 1.02% to $13.2 billion in 2026.
- According to Business Quant data, Assets over the past three periods registered $13.2 billion, $13.4 billion, and $13.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 6.18 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 4.39 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.56 Bn |
| Mar 31, 2026 | 13.22 Bn |
| Dec 31, 2025 | 13.36 Bn |
| Sep 30, 2025 | 13.55 Bn |
| Jun 30, 2025 | 13.74 Bn |
| Mar 31, 2025 | 12.94 Bn |
| Dec 31, 2024 | 12.61 Bn |
| Sep 30, 2024 | 13.28 Bn |
| Jun 30, 2024 | 13.76 Bn |
| Mar 31, 2024 | 14.02 Bn |
| Dec 31, 2023 | 14.36 Bn |
| Sep 30, 2023 | 14.34 Bn |
| Jun 30, 2023 | 15.80 Bn |
| Mar 31, 2023 | 15.77 Bn |
| Dec 31, 2022 | 15.49 Bn |
| Sep 30, 2022 | 14.95 Bn |
| Jun 30, 2022 | 15.60 Bn |
| Mar 31, 2022 | 16.25 Bn |
| Dec 31, 2021 | 16.48 Bn |
| Sep 30, 2021 | 16.57 Bn |